{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:27:54Z","timestamp":1794749274260,"version":"4.9.1"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T00:00:00Z","timestamp":1236038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Laboratory diagnosis of von Willebrand disease type 2N (VWD2N) is based on costly mutation analysis or <jats:italic>in vitro<\/jats:italic> measurement of the ability of plasma von Willebrand factor (VWF) to bind exogenous factor VIII (FVIII); however, the VWF\u2010FVIII binding activity assay is complex and not widely used. Our aim was to assess the utility of the in\u2010house VWF\u2010FVIII binding assay in the investigation of patients with suspected VWD2N. A previously described ELISA\u2010based FVIII binding method was simplified and adapted for the clinical laboratory use by optimizing incubation time, reagent concentrations and assay standardization. The assay was validated using samples from eight individuals with known homozygous or heterozygous VWD2N mutations, and 100 healthy adults. An additional 392 patient samples were tested, including 314 with FVIII activity &lt;50% of normal and 78 received for routine VWF\u2010FVIII binding activity testing. Intra\u2010 and inter\u2010assay variations were less than 10% and 17%, respectively, and the limit of quantification was estimated as 0.12. The reference range for healthy adults was 0.73\u20131.42. VWF:FVIII binding activity was consistent with the genotype in subjects with available genetic data, being low in three individuals with homozygous mutation (&lt;0.12) and intermediate in five heterozygous individuals (0.44\u20130.61). Screening of the 392 clinical samples identified reduced VWF:FVIII binding in 19 subjects. This assay provides accurate measurement of VWF:FVIII binding activity and successfully identifies homozygous VWD2N patients and heterozygous carriers. Use of this ELISA\u2010based assay may help avoid the need for mutation analysis in patients with unexplained low FVIII activity.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2009.01995.x","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T01:58:45Z","timestamp":1236131925000},"page":"788-796","source":"Crossref","is-referenced-by-count":16,"title":["Measurement of von Willebrand factor\u2010FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA\u2010based assay in a reference laboratory"],"prefix":"10.1111","volume":"15","author":[{"given":"O.","family":"ZHUKOV","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"POPOV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"RAMOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"VAUSE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"RUDEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"SFERRUZZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"DLOTT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"SAHUD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,21]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613992"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108788"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0038-1648458","article-title":"disease masquerading as haemophilia A","volume":"67","author":"Mazurier C","year":"1992","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0038-1650567","article-title":"Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease\u2010results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH","volume":"76","author":"Mazurier C","year":"1996","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-947870"},{"key":"e_1_2_7_8_2","unstructured":"Published online athttp:\/\/www.vwf.group.shef.ac.uk\/vwd.html. Maintained by D. Hampshire at the University of Sheffield United Kingdom (last accessed on 15 May 2008)."},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.5.1591.1591"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/109.3.347"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03488.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1160\/TH04-05-0292","article-title":"Something new about type Normandy von Willebrand disease (type 2N VWD)?","volume":"92","author":"Mazurier C","year":"2004","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2002.00480.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.958"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05127.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029606299000"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.6.1691.1691"},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0037-1615134","article-title":"Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)\u2010detection of a novel candidate type 2N mutation: C2810T (R854W)","volume":"80","author":"Bowen DJ","year":"1998","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91070-3"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-27820"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/s-0038-1650628","article-title":"Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1","volume":"76","author":"Schneppenheim R","year":"1996","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0138"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01541.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106481"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1309\/2D6F-RR03-8EFN-28F5"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.6.1691.1691"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05249.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2009.01995.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2009.01995.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:06:50Z","timestamp":1697242010000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2009.01995.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,21]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1365-2516.2009.01995.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2009.01995.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,21]]}}}